Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma
A retrospective analysis evaluating safety and efficacy of combining locoregional therapies with anti-VEGF/TKIs and immune checkpoint inhibi…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: MR 7700 Multinuclear Application Clinical Study [NA]
Philips reports a clinical trial for the MR 7700 Multinuclear Application related to hepatocellular carcinoma imaging; the study status is N…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT [Phase 2]
A completed Phase 2 trial evaluating hepatic arterial infusion chemotherapy combined with Lenvatinib and PD-1 inhibitors for advanced hepato…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: First in Human Study of SIM0610 in Solid Tumors [Phase 1]
A first-in-human Phase 1 study of SIM0610 in solid tumors is underway, evaluating safety and dosing across multiple indications including No…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus [Phase 2]
A Phase 2 clinical trial is evaluating radiotherapy in combination with tislelizumab and anlotinib for hepatocellular carcinoma with portal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating SH006 injection combination therapy in patients with advanced solid tumors, with current focus on liver ca…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating drug sensitivity testing-based tumor organoids to guide adjuvant therapy after liver tumor resection.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Phase I Study of CREPT-618 in Locally Advanced HCC [Phase 1]
Phase I study evaluating CREPT-618 in locally advanced Hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma [NA]
A clinical trial update for Yttrium-90 radiation segmentectomy in unresectable hepatocellular carcinoma. The study status is NOT_YET_RECRUIT…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers [Phase 2]
Phase 2 study evaluating the PET imaging agent [18F]FAPI-74 in gastrointestinal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
A Zhejiang University-sponsored clinical trial (NCT07359586) is currently recruiting to evaluate laryngopharyngeal injury after endotracheal…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC) [NA]
A Clinical Trials update announcing a study to evaluate CG-102-12C in GPC3-positive advanced hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer [Phase 2]
Phase 2 trial comparing oral cryotherapy with acupressure/acupuncture versus oral cryotherapy alone to prevent oxaliplatin-induced periphera…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer [Phase 1]
A Phase 1 clinical trial update examining multiple drug combinations including BI 765063, Ezabenlimab, Cetuximab, and BI 836880 for head and…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial [Phase 3]
A Phase 3 randomized trial comparing camrelizumab plus apatinib with hepatic artery infusion chemotherapy (HAIC) versus camrelizumab plus ap…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial update for TC-G203 in patients with GPC3-positive advanced solid tumors, including hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study [Phase 2]
Phase 2 RELIEF-NAFLD trial update evaluating lisinopril to prevent progression of non-alcoholic fatty liver disease and nonalcoholic steatoh…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating olanzapine for cancer-associated appetite loss in patients with advanced esophageal, gastric, colorec…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer [NA]
A recruiting clinical trial is evaluating the safety and efficacy of a tumor thermosensitive embolic agent used with transcatheter arterial …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. [Phase 4]
Phase 4 clinical trial update on managing hepatitis B and HPV-related cancers and associated mental health conditions. The study is currentl…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cabozantinib plus durvalumab with or without tremelimumab in patients with gastroesophageal cancer and o…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma [Phase 3]
A Phase 3 clinical trial update for nanocrystalline Megestrol Acetate aimed at treating cachexia in patients with stage locally advanced hep…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma [Phase 1]
A Phase 1 clinical trial evaluating the safety and potential efficacy of the armored CAR-T cell therapy C-CAR031 in advanced hepatocellular …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3 [NA]
A preliminary evaluation of a SPECT-CT imaging approach targeting GPC3 for hepatocellular carcinoma, currently not yet recruiting.